GENPACT LIMITED – Trademark Portfolio
Entity Type: 03
GENPACT LIMITED holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 8 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 4 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include SEP and GENPACT. The owner is based in HAMILTON.
CANONS COURT, 22 VICTORIA STREET
HAMILTON HM 12 , BM
Showing of trademarks Trademarks
Trademark Classifications
GENPACT LIMITED's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Scientific and technological services; industrial analysis and research services
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does GENPACT LIMITED have?
GENPACT LIMITED has 12 U.S. trademarks filed with the USPTO. Of these, 5 registered, 7 abandoned.
What trademark classes does GENPACT LIMITED file in?
GENPACT LIMITED files trademarks across 4 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 36 (Insurance & Financial). Class 35 covers advertising; business management; business administration; office functions.
What are GENPACT LIMITED's most well-known trademarks?
GENPACT LIMITED's registered trademark portfolio includes well-known marks such as SEP and GENPACT. These are among 5 currently registered trademarks in the portfolio.
What is GENPACT LIMITED's trademark registration success rate?
GENPACT LIMITED has a 42% trademark registration rate, with 5 out of 12 resolved applications resulting in successful registration. Currently, 0 applications are pending review.